Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a ...

Drugs used to treat diabetes and obesity, or GLP-1 (Glucagon-like peptide-1), will be a significant growth driver for ...

Her suggestions included adding dupilumab and other biologics to the list of subsidised drugs and for moderate to severe ...

Medicare drug price negotiation could have significant impacts on investment in post-approval studies for cancer treatment ...

Danish drug maker Novo Nordisk said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% ...

At GEN’s inaugural virtual summit on The State of AI in Drug Discovery, experts evaluated the evolution, opportunities, and ...

One company is determined to improve drug development success rates, and its cell simulation platform is already being used ...

A coalition of pharmaceutical companies and conservation groups launched the Sustainability Scorecard for Endotoxin Testing ...

Egypt was added to the list of malaria-free places in 2024, but climate change, conflict and other threats could increase cases especially in Africa.

The report from The Insight Partners lists several stakeholders—including pharmaceutical companies, CROs, and academic ...

For those of us diagnosed with a rare disease, the Orphan Drug Act of 1982 has been a lighthouse of hope for a perilous journey. The ODA recognized the lethal ...